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 Supplemental Figure 1. Effects of KAB-18 on [3H]Epibatidine to nAChRs. 
Competition binding experiments were performed on membrane homogenates from 
bovine adrenal medulla (BAM) (González-Cestari et al., 2009) or HEK tsA201 cells 
stably expressing human (Hα4β2) nAChRs using the indicated concentration of KAB-
18. Data are expressed as a percentage of control specific binding. Values represent 
means ± S.E.M. (n = 3-5). 
  
 Supplemental Figure 2. Concentration Response Effects of KAB-18 on WT and 
Mutant Transiently Transfected Hα4β2 nAChRs. Inhibition curves represented in 
Figure 3D of the main paper were separated for closer examination of the mutant and 
WT Hα4β2 nAChRs. Curves were fit to the exact same parameters as the compiled 
curves of Figure 3D. 
Supplemental Methods. 
 
[3H]Epibatidine Binding to Native and Recombinant nAChRs. Membrane 
preparations from bovine adrenal medullary (BAM) tissues or HEK tsA201 293 cells 
stably expressing Hα4β2 nAChRs were prepared, and binding assays were performed, 
as described previously by our laboratory (Free et al., 2003; González-Cestari et al., 
2009). Briefly, membranes were incubated at room temperature for 60 min in buffer 
containing 1 nM (BAM) or 200 pM (Hα4β2) of [3H]epibatidine. Nonspecific binding was 
determined in the presence of 300 µM nicotine. Non-specific binding was typically 1 to 
2% of total binding for recombinant nAChRs and 5 to 10% for native nAChRs.  
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